Effect of COVID-19 and Face Masks on the Condition of Rosacea – A Retrospective Analysis of 87 Patients

Figures & data

Figure 1 (A) The number of patients with rosacea infected with COVID-19. (B) The post-infection symptoms of patients with rosacea infected with COVID-19.

Table 1 Changes of Rosacea Patients Infected with COVID-19

	Alleviation	No Influence	Aggravation	Z/χ^2	P
Body temperature
Fever (n=48)	2 (4.17%)	27 (56.25%)	19 (39.58%)	−1.215	0.225
No Fever (n=25)	1 (4.00%)	18 (72.00%)	6 (24.00%)
Fever level
Low (n=14)	0 (0)	10 (71.43%)	4 (28.57%)	2.474	0.290
Moderate (n=21)	1 (4.76%)	13 (61.90%)	7 (33.34%)
High (n=13)	1 (7.69%)	4 (30.77%)	8 (61.54%)
Condition of taking antipyretic medicine
Yes (n=32)	2 (6.25%)	16 (50.0%)	14 (43.75%)	−0.527	0.598
No (n=16)	0 (0)	11 (68.75%)	5 (31.25%)
COVID-19 Vaccination
Once or less (n=7)	0 (0)	4 (57.14%)	3 (42.86%)	−0.616	0.538
Two or three (n=66)	3 (4.55%)	41 (62.12%)	22 (33.33%)

Table 2 The Relationship Between Mask Use and Disease Change in Rosacea Patients

	Aggravation	No Influence	χ^2	P
Mask type
N95 respirator (n=9)	5 (55.56%)	4 (44.44%)	7.415	0.025
Common respirator (n=42)	33 (78.57%)	9 (21.43%)
Hospital respirator (n=36)	25 (69.44%)	11 (30.56%)
Mask wearing
<4h (n=66)	48 (72.73%)	18 (27.27%)	0.013	0.908
≥4h (n=21)	15 (71.43%)	6 (28.57%)

Figure 2 The relationship between mask usage and disease change in rosacea patients.